

Some of the statements attributed to leading vets and scientists around the world in the last few months would probably lead anyone involved in horseracing to believe that it is only a matter of months or even weeks before the diuretic furosemide (or frusemide), often referred to by the brand name Lasix® or Salix®, becomes permitted raceday medication in the jurisdictions that currently do not allow it (including most of Europe, Australia, Hong Kong and Japan).
The impetus for the statements was the publication of a long-awaited study into the effect of Lasix on exercise-induced pulmonary hemorrhage (EIPH or “bleeding”) in Thoroughbred racehorses in South Africa.
Read the full article online...
The South African study was led by Prof. Ken Hinchcliff, Dean of the Veterinary School in Melbourne, Australia. Additional investigators included Prof. Paul Morley, a veterinary statistician from Colorado State University, and Prof. Alan Guthrie, Dean of the Veterinary School in Pretoria, South Africa. Ken Hinchcliff is rightly considered a world leader in the field of EIPH. He and I organized and co-chaired the first Havemeyer International Workshop on EIPH in Vancouver in March 2006. The recent study was entitled “Efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage in Thoroughbred racehorses” and was published on July 1st, 2009 in the Journal of the American Veterinary Medical Association. What was relatively unusual about this study was the number of horses involved – an incredible 167 racehorses. The funding to undertake this study came from the racing industry in South Africa, including the track operators, US funding bodies and private donors. I shudder at the thought of the true bottom line figure. The authors utilized all the appropriate techniques to ensure accurate results, including such things as placebos, not telling the jockeys which horses had which treatment, and running half the horses with Lasix first and half without, and then running them again but the ones that had Lasix the first time ran without it the second time. There is no doubt that this study has set a standard which others will find hard to match, at least if the cost is taken into account.
But what were the results and how should we interpret them? Horses that were given Lasix had less blood in the trachea (windpipe) when scoped after racing than when they were given a placebo (salt water). Lasix did not, however, abolish EIPH completely. The degree of bleeding is most commonly scored by grading the amount of blood in the trachea after exercise on a 0-4 scale, with 0 being no blood and 4 meaning the trachea would be awash with blood. In this study there was a small number of horses that had severe bleeding (grades 3 and 4) when running without Lasix, but none when running with Lasix. In addition, twice the number of horses had no blood in the trachea when they ran with Lasix compared to when they ran without it. This does not mean that Lasix abolishe...
Subscribe today! From just $20 per annum and read our articles online and in the magazine delivered to your door.
Comments
Add A Comment